EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis

Wieke M van Oostveen iD, Eva M Hoekstra iD, E W Nivine Levarht, Ilana B Kotliar, Thomas P Sakmar, René E M Toes, Jeska K de Vries-Bouwstra, Laura H Heitman, Cynthia M Fehres iD

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.43099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Wieke M van Oostveen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Receptor, Endothelin A, Receptor, Angiotensin, Type 1, Autoantibodies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Health~Holland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Systemic sclerosis (SSc) is a rare but severe autoimmune disease characterized by immune dysregulation, fibrosis, and vasculopathy. Although previous studies have highlighted the presence of functional autoantibodies targeting the angiotensin II receptor type 1 (AT 1 ) and endothelin‐1 type A receptor (ET A R), leading to autoantibody‐mediated receptor stimulation and subsequent activation of endothelial cells (ECs), a comprehensive understanding of the direct interaction between these autoantibodies and their receptors is currently lacking. Moreover, existing data confirming the presence of these autoantibodies in SSc often rely on similar methodologies and assays. Our aim was to replicate previous findings and to investigate the functional effects of IgG derived from patients with SSc (SSc IgG) on AT 1 and ET A R signaling, the downstream EC response, and the presence of AT 1 ‐binding autoantibodies in circulation.

Methods

Quantitative polymerase chain reaction and cytokine enzyme‐linked immunosorbent assay, alongside a real‐time cell analyzer, were used to assess receptor‐specific functional characteristics of purified SSc IgG (n = 18). Additionally, a novel protein capture assay using solubilized epitope‐tagged AT 1 was developed to detect AT 1 ‐binding autoantibodies in plasma samples from patients with SSc (n = 28) and healthy donors (n = 14).

Results

No evidence for EC activation in an AT 1 ‐ or ET A R‐dependent manner was revealed. Furthermore, stimulation with SSc IgG did not induce receptor activation or alter G protein‐coupled receptor signaling on agonist stimulation in a model with receptor overexpression. Lastly, no AT 1 ‐binding autoantibodies were detected in plasma samples from patients with SSc when using epitope‐tagged solubilized AT 1 .

Conclusion

Overall, our study did not provide evidence to support the presence of AT 1 ‐ or ET A R‐activating autoantibodies in purified SSc IgG or AT 1 ‐binding autoantibodies in the circulation of patients with SSc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicReceptor, Endothelin AReceptor, Angiotensin, Type 1AutoantibodiesImmunoglobulin GHumansFemaleMiddle AgedMaleEndothelial CellsAdultAgedSignal Transduction

Substanzen

Receptor, Endothelin AReceptor, Angiotensin, Type 1AutoantibodiesImmunoglobulin G

Autor:innen und Institutionen

  • Leiden University Medical Center, Leiden, The Netherlands.
  • The Rockefeller University and Tri-Institutional PhD Program in Chemical Biology, New York, New York.
  • The Rockefeller University, New York, New York.
  • Leiden University and Oncode Institute, Leiden, The Netherlands.

ORCID-Profile: Wieke M van Oostveen, Eva M Hoekstra, Cynthia M Fehres

Förderung

  • NIGMS NIH HHS
  • Health~Holland

Zitieren

APA

van Oostveen, W. M., Hoekstra, E. M., Levarht, E. W. N., Kotliar, I. B., Sakmar, T. P., Toes, R. E. M., de Vries-Bouwstra, J. K., Heitman, L. H., & Fehres, C. M. (2025). Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43099

Vancouver

van Oostveen WM, Hoekstra EM, Levarht EWN, Kotliar IB, Sakmar TP, Toes REM, et al. Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis. Arthritis & Rheumatology. 2025. doi:10.1002/art.43099

BibTeX
@article{vanOostveen2025,
  author = {van Oostveen, Wieke M and Hoekstra, Eva M and Levarht, E W Nivine and Kotliar, Ilana B and Sakmar, Thomas P and Toes, René E M and de Vries-Bouwstra, Jeska K and Heitman, Laura H and Fehres, Cynthia M},
  title = {Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.43099}
}
Kostenlos starten →